When reviewing the treatment options for LOCALIZED prostate cancer you should study the complications associated with these individual treatment options. Especially so since the SURVIVAL BENEFITS of the four standard treatment options, HIFU, cryoablation,radiation and surgery are SIMILAR but the incidence of their complications are very different and these COMPLICATIONS affect not only the patient but the spouse and their partnership.
In addition, you should review the respective benefits of these four treatment options and also realize prostate cancer can be cured without the prostate having to be cut out through radical/robotic prostatectomy.
In that regard,minimally invasive HIFU is a clear leader as a treatment option for localized prostate cancer with many upsides and very few downsides.
The following HIFU benefits are listed:
> can cure localized prostate cancer
> can cure without sacrificing quality of life (QoL)
> low incidence of side effects and complications
> truly minimally invasive with no overnight hospitalization
> non surgical (no incisions)
> quickest recovery with men ambulating at home within hours of the procedure
> no Foley catheter (no tube in penis)
> most precise of all treatment options
> real time monitoring of neuro-vascular bundles and urinary sphincter helps preserve erections and urine control.
> non radiation. HIFU is clean acoustic energy
> no blood loss
> unlike radiation or cryoablation, HIFU results in expulsion of treated cancerous prostate tissue
> no penile shortening ( the trifecta of complications associated with surgery are: urinary incontinence,impotence and penile shortening)
> treatment is repeatable
> HIFU is ideal for prostate cancer recurrences after surgery, radiation and cryoablation
It is important for the patient and his spouse to do their homework on treatment options for localized prostate cancer. Get the facts on these treatment options and the benefits of HIFU and get it right the first time.
Do NOT let yourself become another miserable statistic with permanent debilitating urinary incontinence and/or impotence after a radical/robotic prostatectomy.